COPENHAGEN, Denmark, March 11, 2026 (GLOBE NEWSWIRE)-- Commit Biologics ("Commit"), a biotechnology company pioneering complement system activation and backed by €21.5 million in seed financing from ...
Long Covid patients suffer from chronic symptoms such as fatigue or shortness of breath. As researchers have discovered, this is to some extent due to a part of our immune system called the complement ...
COM002 is a first-in-class complement-powered immune engager based on Commit Biologics proprietary BiCE platform.Anne-Marie Levy Rasmussen appointed Chief Operating ...
Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system-a group of proteins that ...
Changes to serum proteins could be behind the debilitating condition known as long COVID. The findings, published in the journal Science, could pave the way for diagnosing and treating the disease.
Patients in intensive care are exposed to the risk of microparticle infusion via extracorporeal lines and the resulting complications. A possible source of ...
Dianthus achieved its NASDAQ listing last year via a merger with Magenta Therapeutics. The company is focused on development of a single drug candidate, DNTH-103, which targets the complement system, ...
Most people infected with the SARS-CoV-2 virus recover after the acute illness. However, a significant proportion of infected individuals develop long-lasting symptoms with a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results